ResearcherJiangsu UniversityNo recent work listed

Bin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2662-1986; OpenAlex author ID A5100665448. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers

Papers 4

Long non-coding RNAs and pancreatic cancer: A multifaceted view. Co-author DOI 10.1016/j.biopha.2023.115601 ↗
M2 macrophage-derived exosomal long noncoding RNA Myt1l promotes lung metastasis of pancreatic cancer cells via the miR-135/Slug axis Co-author DOI 10.21203/rs.3.rs-3239578/v1 ↗
Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. Co-author PMID 31312365 ↗
HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. Co-author DOI 10.18632/oncotarget.2200 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sheng-Chun Dang · 2 shared papers, 2023 · strength 0.65
- Paper M2 macrophage-derived exosomal long noncoding RNA Myt1l promotes lung metastasis of pancreatic cancer cells via the miR… DOI 10.21203/rs.3.rs-3239578/v1 ↗
- Paper Long non-coding RNAs and pancreatic cancer: A multifaceted view. DOI 10.1016/j.biopha.2023.115601 ↗
Zhi‐Nan Chen · 1 shared paper, 2019 · strength 0.09
- Paper Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. PMID 31312365 ↗
Jian‐Li Jiang · 1 shared paper, 2019 · strength 0.09
- Paper Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. PMID 31312365 ↗
Liang Xu · 1 shared paper, 2019 · strength 0.09
- Paper Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. PMID 31312365 ↗
Xiaoqing Wu · 1 shared paper, 2019 · strength 0.09
- Paper Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. PMID 31312365 ↗
Xinyu Fan · 1 shared paper, 2019 · strength 0.09
- Paper Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. PMID 31312365 ↗
Zekuan Xu · 1 shared paper, 2014 · strength 0.04
- Paper HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. DOI 10.18632/oncotarget.2200 ↗
Guoxin Zhang · 1 shared paper, 2014 · strength 0.04
- Paper HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. DOI 10.18632/oncotarget.2200 ↗
Zheng Chen · 1 shared paper, 2014 · strength 0.04
- Paper HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. DOI 10.18632/oncotarget.2200 ↗
Wenjie Zhang · 1 shared paper, 2014 · strength 0.04
- Paper HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. DOI 10.18632/oncotarget.2200 ↗
Jin Feng · 1 shared paper, 2014 · strength 0.04
- Paper HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96. DOI 10.18632/oncotarget.2200 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.